ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01947959
Recruitment Status : Active, not recruiting
First Posted : September 23, 2013
Last Update Posted : July 6, 2018
Sponsor:
Collaborator:
Janssen Research & Development, LLC
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 31, 2018
  Estimated Study Completion Date : December 31, 2019